CRISPR Therapeutics AG
NASDAQ:CRSP
42.12 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 298.257 | 389.477 | 211.885 | 923.031 | 1,168.62 | 943.771 | 456.649 | 239.758 | 315.52 | 155.961 | 0.945 |
| Short Term Investments
| 1,605.569 | 1,304.215 | 1,603.433 | 1,456.098 | 521.713 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 1,903.826 | 1,693.692 | 1,815.318 | 2,379.129 | 1,690.333 | 943.771 | 456.649 | 239.758 | 315.52 | 155.961 | 0.945 |
| Net Receivables
| 25 | 200 | 0 | 0.305 | 0.144 | 0.099 | 0.088 | 2.626 | 3.157 | 0.339 | 0 |
| Inventory
| 0 | 0 | -11.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 8.306 | 14.386 | 37.708 | 29.679 | 15.443 | 6.977 | 15.916 | 12.002 | 3.022 | 0.54 | 0.023 |
| Total Current Assets
| 1,937.132 | 1,908.078 | 1,853.026 | 2,417.513 | 1,716.62 | 987.547 | 466.395 | 248.385 | 320.188 | 156.84 | 0.968 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 277.554 | 305.938 | 320.555 | 312.035 | 93.025 | 72.832 | 18.5 | 18.857 | 21.027 | 1.328 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0.016 | 0.071 | 0.125 | 0.18 | 0.235 | 0.289 | 0.344 | 0.399 | 0.454 | 0.509 |
| Goodwill and Intangible Assets
| 0 | 0.016 | 0.071 | 0.125 | 0.18 | 0.235 | 0.289 | 0.344 | 0.399 | 0.454 | 0.509 |
| Long Term Investments
| 0 | 1.973 | 53.13 | 16.913 | 16.848 | 5.041 | 3.163 | 3.154 | 3.15 | 0.7 | 0 |
| Tax Assets
| 0 | 0 | 0 | -16.913 | -16.848 | -5.041 | -3.163 | -3.154 | -3.15 | -0.7 | 0 |
| Other Non-Current Assets
| 27.348 | 13.566 | 16.275 | 22.204 | 18.141 | 6.138 | 3.832 | 3.76 | 3.348 | 0.801 | 0.05 |
| Total Non-Current Assets
| 304.902 | 321.493 | 390.031 | 334.364 | 111.346 | 79.205 | 22.621 | 22.961 | 24.774 | 2.583 | 0.559 |
| Total Assets
| 2,242.034 | 2,229.571 | 2,243.057 | 2,751.877 | 1,827.966 | 1,066.752 | 489.016 | 271.346 | 344.962 | 159.423 | 1.527 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 14.709 | 38.147 | 27.428 | 14.816 | 9.094 | 5.944 | 5.069 | 1.639 | 4.569 | 1.584 | 0.211 |
| Short Term Debt
| 17.288 | 43.613 | 31.684 | 24.316 | 22.724 | 16.978 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0.451 | 0.438 | 0.135 | 0.724 | 10.473 | 0.583 | 0.402 | 0.347 | 0.023 | 0.081 | 0.011 |
| Deferred Revenue
| 3.845 | 4.105 | 12.323 | 1.011 | 2.341 | 0.96 | 57.78 | 56.928 | 77.646 | 0 | 0 |
| Other Current Liabilities
| 51.489 | 50.476 | 61.86 | 79.016 | 49.627 | 32.641 | 22.275 | 12.525 | 17.406 | 8.49 | 1.924 |
| Total Current Liabilities
| 87.782 | 108.791 | 121.107 | 119.883 | 94.259 | 57.106 | 27.746 | 14.511 | 21.998 | 10.155 | 2.146 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 206.405 | 223.007 | 228.179 | 212.872 | 50.067 | 44.05 | 0 | 0 | 0 | -26.185 | 0 |
| Deferred Revenue Non-Current
| 0 | 14.012 | 12.323 | 12.323 | 11.776 | 11.776 | 57.78 | 56.928 | 77.646 | 75.09 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 64.521 | 0 |
| Other Non-Current Liabilities
| 15.767 | 0.958 | 5.969 | 7.339 | 7.63 | 14.395 | 11.295 | 12.075 | 12.472 | -64.076 | 6.355 |
| Total Non-Current Liabilities
| 222.172 | 237.977 | 246.471 | 232.534 | 69.473 | 70.221 | 69.075 | 69.003 | 90.118 | 178.392 | 6.355 |
| Total Liabilities
| 309.954 | 346.768 | 367.578 | 352.417 | 163.732 | 127.327 | 96.821 | 83.514 | 112.116 | 188.547 | 8.501 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 64.521 | 6.27 |
| Common Stock
| 2.698 | 2.497 | 2.441 | 2.391 | 2.277 | 1.847 | 1.584 | 1.24 | 1.216 | 0.181 | 0.12 |
| Retained Earnings
| -1,365.952 | -999.7 | -846.09 | -195.915 | -573.576 | -224.711 | -291.569 | -125.44 | -57.083 | -33.906 | -8.403 |
| Accumulated Other Comprehensive Income/Loss
| 1.84 | 1.913 | -15.647 | -5.067 | -0.083 | 0.007 | -0.008 | 0.014 | -0.026 | -0.008 | -0.002 |
| Other Total Stockholders Equity
| 3,293.494 | 2,878.093 | 2,734.775 | 2,598.051 | 2,235.616 | 1,162.282 | 682.188 | 312.018 | 288.739 | -64.521 | -6.27 |
| Total Shareholders Equity
| 1,932.08 | 1,882.803 | 1,875.479 | 2,399.46 | 1,664.234 | 939.425 | 392.195 | 187.832 | 232.846 | -29.097 | -7.117 |
| Total Equity
| 1,932.08 | 1,882.803 | 1,875.479 | 2,399.46 | 1,664.234 | 939.425 | 392.195 | 187.832 | 232.846 | -29.124 | -6.974 |
| Total Liabilities & Shareholders Equity
| 2,242.034 | 2,229.571 | 2,243.057 | 2,751.877 | 1,827.966 | 1,066.752 | 489.016 | 271.346 | 344.962 | 159.423 | 1.527 |